AMZN
61
2
CL
50
2
TXT
59
6
UNP
48
6
HRL
30
3
CPB
30
5
MDLZ
38
2
HPQ
53
3
INTC
44
5
TROW
54
6
BRK.B
27
2
NSC
53
6
VMC
62
5
IVZ
52
6
CHD
45
3
HRB
56
2
OI
34
6
NVDA
55
4
AEP
48
5
JBHT
63
3
AMZN
61
2
CL
50
2
TXT
59
6
UNP
48
6
HRL
30
3
CPB
30
5
MDLZ
38
2
HPQ
53
3
INTC
44
5
TROW
54
6
BRK.B
27
2
NSC
53
6
VMC
62
5
IVZ
52
6
CHD
45
3
HRB
56
2
OI
34
6
NVDA
55
4
AEP
48
5
JBHT
63
3
Financhill
Back

MEI Pharma 10K Form

Buy
61

MEIP
MEI Pharma

Last Price:
3.09
Seasonality Move:
4.33%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MEIP News And Ratings

See the #1 stock for the next 7 days that we like better than MEIP

MEIP Financial Statistics

Sales & Book Value

Annual Sales: $65.3M
Cash Flow: $-18M
Price / Cash Flow: 0
Annual Sales: $4.96
Price / Book: 0.61

Profitability

EPS (TTM): 2.67000
Net Income (TTM): $17.78M
Gross Margin: $40.7M
Return on Equity: 0%
Return on Assets: 0%

MEI Pharma Earnings Forecast

Key MEI Pharma Financial Ratios

  • The Gross Profit Margin over the past 20 years for MEIP is 100.01%.
  • The Selling, General & Administrative Expenses for MEIP have been equal to 35.68% of Gross Profit Margin.
  • The Research & Development expenses have been 25.36% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 23 years have been positive in 15 years.

MEI Pharma Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MEIP
CUSIP: 55279B
Website: meipharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 1.14
Forward P/E Ratio: 0

MEIP Technical Analysis vs Fundamental Analysis

Buy
61
MEI Pharma (MEIP) is a Buy

Is MEI Pharma a Buy or a Sell?

  • MEI Pharma stock is rated a Buy
    The current MEI Pharma [MEIP] share price is $3.04. The Score for MEIP is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.